Loading, Please Wait...
Agreement represents first contract for AutoEncoder as a standalone coding solution
Fort Lauderdale, Fla., Jan. 30, 2019 (GLOBE NEWSWIRE) -- A leading global contract research organization, ranked among the top 5 of international CROs, has signed a contract for OmniComm’s AutoEncoder, a user-friendly tool for coding clinical data against medical dictionaries. The agreement represents the first standalone contract for AutoEncoder, which was introduced in April of 2018 by OmniComm Systems, Inc. (OTCQX: OMCM), a leading global provider of clinical data management technology.
The global CRO has contracted to use AutoEncoder, technical support, hosting and related professional services from OmniComm.
“This is a key step forward for OmniComm as this contract will cover use of our coding tool against data that has been collected in another vendor’s EDC system,” said Kuno van der Post, Ph.D., chief commercial officer at OmniComm.“We have built this product organically from the ground up, making it the most modern coding tool in the marketplace today.”
Coding is a unique and necessary process required by regulators during clinical trials or when monitoring the safety of approved products. Regulatory agencies require that adverse events be coded against the MedDRA dictionary, and that medications be coded against the WHO Drug dictionary. The coding process is performed by specialist medical professionals, who must ensure consistent and accurate decisions based on the content of the source term, any relevant related data, and prior decisions for the trial or drug project.
The OmniComm AutoEncoder provides a modern and sophisticated tool for performing these coding activities. Out of the box, AutoEncoder is fully integrated with OmniComm’s TrialMaster® product for Electronic Data Capture, and its open interfaces also allow for integration with any third-party EDC or safety reporting system. Terms may also be loaded in bulk from an ASCII file. These features may be used to code data for the first time or to recode existing data against a new dictionary version.
About OmniComm Systems, Inc.
OmniComm Systems, Inc. is a leading strategic software solutions provider to the life sciences industry. OmniComm is dedicated to helping the world’s pharmaceutical, biotechnology, contract research organizations, diagnostic and device firms, and academic medical centers maximize the value of their clinical research investments. Through the use of innovative and progressive technologies, research organizations drive efficiency in clinical development, better manage risks, ensure regulatory compliance and manage their clinical operations performance. OmniComm provides comprehensive solutions for clinical research with an extensive global experience from more than 6,000 clinical trials. Please visit www.omnicomm.com for more information, and follow OmniComm on Twitter: @OmniCommSystems, on LinkedIn: @OmniComm Systems and Facebook: @OmniComm Systems, Inc.
OmniComm, Promasys, TrialMaster and TrialOne are registered trademarks of OmniComm Systems, Inc. Other names may be trademarks of their respective owners.
Contact Info Kuno van der Post, Ph.D. OmniComm Systems, Inc. +1.954.473.1254 KvanderPost@omnicomm.com